RAC 0.00% $1.61 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-52

  1. 2,708 Posts.
    lightbulb Created with Sketch. 2824
    interested to see if the NMR drug discovery program goes down the path of identifying an ALKBH5 inhibitor. aLkBH5 knockdown appears to increase cardiotoxicity the same as an FTO inhibitor.

    https://hotcopper.com.au/data/attachments/6165/6165368-97f8e26ebf3b10035ebed47e2ee55abb.jpg
    Or perhaps a non-cytotoxic FTO / ALKBH5 inhibitor for other metabolic disorders?

    https://hotcopper.com.au/data/attachments/6165/6165374-ed71c2444481af1d22609779fbca3311.jpg


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
0.000(0.00%)
Mkt cap ! $273.4M
Open High Low Value Volume
$1.61 $1.66 $1.60 $207.2K 127.1K

Buyers (Bids)

No. Vol. Price($)
6 25510 $1.60
 

Sellers (Offers)

Price($) Vol. No.
$1.64 12000 1
View Market Depth
Last trade - 15.49pm 29/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.